Advertisement

Obesity Surgery

, Volume 30, Issue 1, pp 69–76 | Cite as

Intraoperative Liver Biopsy During Adolescent Bariatric Surgery: Is It Really Necessary?

  • R. Ellen Jones
  • Ann Ming Yeh
  • Neerajah Kambham
  • Marwa Abu El Haija
  • Janey Pratt
  • Matias BruzoniEmail author
Original Contributions

Abstract

Background

Nonalcoholic fatty liver disease (NAFLD) is prevalent in children with obesity and is definitively diagnosed with liver biopsy. However, the utility of routine biopsy during adolescent bariatric surgery remains unknown. We describe the usefulness of routine versus selective intraoperative liver biopsy in adolescents undergoing bariatric surgery.

Methods

A retrospective review of adolescents who received bariatric surgery at our institution between 2007 and 2018 was performed. Prior to 2014, all patients routinely received intraoperative liver biopsy. After 2014, biopsy was performed selectively on an individual basis for transaminitis or clinical concern. Demographic, biochemical, and histopathologic data were compared between patients who underwent routine, selective, or no biopsy.

Results

There were 77 patients who received bariatric surgery during the study period: 32 underwent routine biopsy, 13 selective biopsy, and 32 no biopsy. Selective liver biopsy was more likely to show pathologic evidence of fibrosis (84.6% versus 31.2%, p = 0.000) and steatosis (100.0% versus 59.4%, p = 0.003), and higher mean NAFLD activity score compared with routine biopsies (4.4 versus 2.1, p = 0.001). Patients with steatosis had significantly higher preoperative fasting insulin (41.4 versus 21.1 mIU/L, p = 0.000), and patients with fibrosis had significantly higher glycated hemoglobin (6.1% versus 5.5%, p = 0.033) and alanine aminotransferase (81.5 versus 52.7 mg/dL, p = 0.043). There were no biopsy complications or changes in management due to biopsy results.

Conclusions

Routine intraoperative liver biopsy during adolescent bariatric surgery possesses questionable benefit, as it does not appear to impact short-term postoperative management. Prospective, longitudinal studies are needed to better understand the meaningfulness of liver histopathology in this population.

Keywords

Liver biopsy Adolescent Bariatric surgery Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis Utility 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflicts of interest.

Human Rights Declaration

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.

References

  1. 1.
    Corey KE, Stanley TL, Misdraji J, et al. Prevalence and outcome of non-alcoholic fatty liver disease in adolescents and young adults undergoing weight loss surgery. Pediatr Obes. 2014;9(5):e91–3.  https://doi.org/10.1111/j.2047-6310.2014.219.x.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Doycheva I, Watt KD, Alkhouri N. Nonalcoholic fatty liver disease in adolescents and young adults: the next frontier in the epidemic. Hepatology. 2017;65(6):2100–9.  https://doi.org/10.1002/hep.29068.CrossRefPubMedGoogle Scholar
  3. 3.
    Holterman A, Gurria J, Tanpure S, et al. Nonalcoholic fatty liver disease and bariatric surgery in adolescents. Semin Pediatr Surg. 2014;23(1):49–57.  https://doi.org/10.1053/j.sempedsurg.2013.10.016.CrossRefPubMedGoogle Scholar
  4. 4.
    Holterman AX, Guzman G, Fantuzzi G, et al. Nonalcoholic fatty liver disease in severely obese adolescent and adult patients. Obesity (Silver Spring). 2013;21(3):591–7.  https://doi.org/10.1002/oby.20174.CrossRefGoogle Scholar
  5. 5.
    Jimenez-Rivera C, Hadjiyannakis S, Davila J, et al. Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity. BMC Pediatr. 2017;17(1):113.  https://doi.org/10.1186/s12887-017-0867-z.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Uppal V, Mansoor S, Furuya KN. Pediatric non-alcoholic fatty liver disease. Curr Gastroenterol Rep. 2016;18(5):24.  https://doi.org/10.1007/s11894-016-0498-9.CrossRefPubMedGoogle Scholar
  7. 7.
    Kleiner DE, Brunt EM, Van Natta M, et al. Nonalcoholic Steatohepatitis Clinical Research N. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–21.  https://doi.org/10.1002/hep.20701.CrossRefPubMedGoogle Scholar
  8. 8.
    Vos MB, Abrams SH, Barlow SE, et al. NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 2017;64(2):319–34.  https://doi.org/10.1097/MPG.0000000000001482.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Koot BGP, Nobili V. Screening for non-alcoholic fatty liver disease in children: do guidelines provide enough guidance? Obes Rev. 2017;18(9):1050–60.  https://doi.org/10.1111/obr.12556.CrossRefPubMedGoogle Scholar
  10. 10.
    Nobili V, Socha P. Pediatric nonalcoholic fatty liver disease: current thinking. J Pediatr Gastroenterol Nutr. 2018;66(2):188–92.  https://doi.org/10.1097/MPG.0000000000001823.CrossRefPubMedGoogle Scholar
  11. 11.
    Shah J, Okubote T, Alkhouri N. Overview of updated practice guidelines for pediatric nonalcoholic fatty liver disease. Gastroenterol Hepatol (NY). 2018;14(7):407–14.Google Scholar
  12. 12.
    Barbois S, Arvieux C, Leroy V, et al. Benefit-risk of intraoperative liver biopsy during bariatric surgery: review and perspectives. Surg Obes Relat Dis. 2017;13(10):1780–6.  https://doi.org/10.1016/j.soard.2017.07.032.CrossRefPubMedGoogle Scholar
  13. 13.
    Mahawar KK, Parmar C, Graham Y, et al. Routine liver biopsy during bariatric surgery: an analysis of evidence base. Obes Surg. 2016;26(1):177–81.  https://doi.org/10.1007/s11695-015-1916-z.CrossRefPubMedGoogle Scholar
  14. 14.
    Xanthakos SA, Jenkins TM, Kleiner DE, et al. High prevalence of nonalcoholic fatty liver disease in adolescents undergoing bariatric surgery. Gastroenterology. 2015;149(3):623–34 e8.  https://doi.org/10.1053/j.gastro.2015.05.039.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.CrossRefGoogle Scholar
  16. 16.
    Boza C, Viscido G, Salinas J, et al. Laparoscopic sleeve gastrectomy in obese adolescents: results in 51 patients. Surg Obes Relat Dis. 2012;8(2):133–7; discussion 7-9.  https://doi.org/10.1016/j.soard.2011.11.021.CrossRefPubMedGoogle Scholar
  17. 17.
    Holterman AX, Holterman M, Browne A, et al. Patterns of surgical weight loss and resolution of metabolic abnormalities in superobese bariatric adolescents. J Pediatr Surg. 2012;47(9):1633–9.  https://doi.org/10.1016/j.jpedsurg.2012.02.002.CrossRefPubMedGoogle Scholar
  18. 18.
    Loy JJ, Youn HA, Schwack B, et al. Improvement in nonalcoholic fatty liver disease and metabolic syndrome in adolescents undergoing bariatric surgery. Surg Obes Relat Dis. 2015;11(2):442–9.  https://doi.org/10.1016/j.soard.2014.11.010.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Surgery, Division of Pediatric SurgeryStanford University Medical CenterStanfordUSA
  2. 2.Department of Pediatrics, Division of GastroenterologyStanford University Medical CenterStanfordUSA
  3. 3.Department of Clinical PathologyStanford University Medical CenterStanfordUSA

Personalised recommendations